A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

What causes long Covid? Scientists don't fully understand why some develop disabling chronic complications after recovering ...

US President Donald Trump’s recent executive order to freeze USAID’s funding means Nyumbani’s access to life-saving antiretroviral drugs, which stop the HIV virus from replicating in the ...

(AP Photo/Brian Inganga) CORRECTS MONTH -Children play at the Nyumbani Children’s Home orphanage which is heavily reliant on foreign donations and cares for children with HIV whose parents died of the ...